Subclinical thyrotoxicosis and the heart

Lynn A. Burmeister, Angel Flores

Research output: Contribution to journalReview article

24 Scopus citations

Abstract

Subclinical thyrotoxicosis is defined as a below normal thyrotropin (TSH) in association with a normal total and free thyroxine (T4) and triiodothyronine (T3). It may be caused by thyroid hormone treatment or by endogenous thyroid disease. The degree of thyrotoxicosis may be estimated by the level of TSH suppression. Subclinical thyrotoxicosis may be associated with changes in cardiac performance and morphology, but this has not been consistently found in all patient populations. Changes may include increased heart rate, increased left ventricular mass index, increased cardiac contractility, diastolic dysfunction, and the induction of ectopic atrial beats or arrhythmias. Cardiac exercise performance may be impaired. Subclinical thyrotoxicosis should be treated in patients with cardiac symptoms or disease. Treatment may include reduction of the thyroid hormone dose, treatment of the underlying thyroid condition, or β-blockers.

Original languageEnglish (US)
Pages (from-to)495-499
Number of pages5
JournalThyroid
Volume12
Issue number6
DOIs
StatePublished - Jan 1 2002

Fingerprint Dive into the research topics of 'Subclinical thyrotoxicosis and the heart'. Together they form a unique fingerprint.

  • Cite this